PRVA
Privia Health Group Inc
NASDAQ: PRVA · HEALTHCARE · HEALTH INFORMATION SERVICES
$22.76
+1.22% today
Updated 2026-06-05
Market cap
$2.95B
P/E ratio
137.82
P/S ratio
1.31x
EPS (TTM)
$0.17
Dividend yield
—
52W range
$19 – $27
Volume
0.9M
WallStSmart proprietary scores
40
out of 100
Grade: D
Sell
Investment rating
6.0
Growth
B7.0
Quality
B+4.0
Profitability
C4.0
Valuation
C3/9
Piotroski F-Score
Weak
2.6
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$31.42
+38.05%
12-Month target
$8.42
-63.01%
Intrinsic (DCF)
—
Margin of safety
—
5 Strong Buy14 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 25.80% QoQ
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.97%
- Negative free cash flow $-49.49M
- P/E 137.82x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.36B | $1.66B | $1.74B | $2.12B | $2.25B |
| Net income | $-8.59M | $23.08M | $14.38M | $22.92M | $3.06M |
| EPS | — | — | — | — | $0.17 |
| Free cash flow | $47.09M | $80.67M | $104.26M | $162.20M | $-49.49M |
| Profit margin | -0.63% | 1.39% | 0.83% | 1.08% | 0.97% |
Peer comparison
Smart narrative
Privia Health Group Inc trades at $22.76. representing a P/E of 137.82x trailing earnings. Our Smart Value Score of 40/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 2.59, it sits in the grey zone. TTM revenue stands at $2.25B. with profit margins at 0.97%.
Frequently asked questions
What is Privia Health Group Inc's stock price?
Privia Health Group Inc (PRVA) trades at $22.76, on a P/E of 137.8x and a P/S of 1.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Privia Health Group Inc overvalued?
Privia Health Group Inc carries a Smart Value Score of 40/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Privia Health Group Inc (PRVA)?
The 12-month analyst consensus target is $31.42, about 38.0% above the current $22.76. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Privia Health Group Inc's revenue?
Privia Health Group Inc's trailing twelve-month revenue is $2.25B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Privia Health Group Inc's Altman Z-Score is 2.59, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.31x
ROE—
Beta0.87
50D MA$22.97
200D MA$23.28
Shares out0.13B
Float0.11B
Short ratio—
Avg volume0.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—